I am contributing here and try to add to the discussion, Aquasea. I did read the report, ... and you actually point it out precisely: ALL Growth. I was saying NO profit for years. As an aside, BUB also grows the number issued shares since June 2017 by roughly 30% per year (starting with 238 Mio shares in June 2017 to a little more than 550 mio shares after this proposed CR.) It is somewhat incredible: the more cash they get, the more sales they do. ... But please correct me. I admit, that I learn have learned from some contributors.
Someone pointed that profit improved by $30 mio recently. I think, that is guilding the lilly. An accountant would say, loss has been reduced by $30 mio. But, hey, accountants are boring.
It is a well established prejudice that there could be quality issues with production in China. Now, a premium manufacturer, smallish in size (market cap of $500 mio), very limited financial muscle, goes there, invest the new cash, will manufacture, manage all the risk, and FINALLY be successful.
I closely follow another milk company KTD, and there were some critical HC contributors of the management also, with some of them pushing for more emphasis on IF. One got to talk to the CEO, and the reply was a little short: "the IF market is "tricky". That is code for "lot of risk for less return". The comments of sales in Chemist Warehouse in this thread, I think, confirm that (at least anecdotally).
I can see that pot of gold on the horizon (production in China, SAMR, Jen Hawkins). But BUBs history is, when ever we got there, it was that bit further away, and we need a bit more cash.
All in good spirit. GLAH
BUB Price at posting:
91.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)